Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

Topic

March 27, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) began supporting the Zimbabwean health ministry in 2016, rolling out services to prevent cervical cancer at health centers in Gutu district. MSF teams provide mentoring, ongoing training, and supervision for Zimbabwean nurses, as well as equipment and technical support. Here are stories from some of our patients:

March 27, 2017

First patent opposition MSF has filed in Europe aims to increase affordable access to hepatitis C drug sofosbuvir for millions

NEW YORK/ROME/GENEVA, MARCH 27, 2017—In an effort to increase access to affordable hepatitis C treatment, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) filed a patent challenge on the lifesaving hepatitis C drug sofosbuvir with the European Patent Office (EPO) today.

March 24, 2017

Patients with drug-resistant tuberculosis (MDR-TB) have to take a fistful of pills and injections daily for up to two years. Side effects of these toxic drugs can include permanent deafness, nausea and vomiting, blindness, and psychosis. After decades without any new TB drugs, two powerful, less toxic medicines were finally released five years ago. But most patients can't get access to them. This needs to change.

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

March 23, 2017

Companies and countries must take urgent action to increase access to these lifesaving treatments

March 22, 2017

NEW YORK, MARCH 22, 2017—A new, heat-stable vaccine is safe and effective against rotavirus, according to results of a recent Doctors Without Borders/Médecins Sans Frontiéres vaccine trial in Niger, published in the New England Journal of Medicine Thursday.

March 22, 2017

ERBIL, IRAQ/NEW YORK, MARCH 22, 2017—Tens of thousands of people are fleeing western Mosul, Iraq, amid a military offensive to recapture the area, with many wounded in the crossfire or suffering from other emergency medical needs, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today.

March 22, 2017

On February 19, Doctors Without Borders/Médecins Sans Frontières (MSF) opened a field trauma hospital with surgical capacity in a village to the south of Mosul. It is composed of two operating theaters, one intensive care unit, an emergency room, an in-patient ward, and other necessary support facilities.

March 22, 2017

It's been one year since the implementation of the EU-Turkey deal that governs how refugees and migrants are transferred in and out of Europe. In order to dispel some commonly held misunderstandings, Doctors Without Borders/Médecins Sans Frontières (MSF) released this video.

March 21, 2017

Winile is a multidrug-resistant tuberculosis (MDR-TB) patient with Doctors Without Borders/Médecins Sans Frontières (MSF) in Swaziland, and one of the many who have lost their hearing due to the toxicity of available MDR-TB drugs. Through an MSF program in Swaziland, she has learned sign language so she can continue to communicate.

Pages